Therapeutic Efficacy and Macrofilaricidal Activity of Doxycycline for the Treatment of River Blindness
Open Access
- 23 December 2014
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 60 (8) , 1199-1207
Abstract
Background. Onchocerca volvulus and lymphatic filariae, causing river blindness and elephantiasis, depend on endosymbiotic Wolbachia bacteria for growth, development, fertility, and survival. Clinical trials have shown that doxycycline treatment eliminates Wolbachia, causing long-term sterilization of adult female filariae and effecting potent macrofilaricidal activity. The continual reinfection by drug-naive worms that occurs in these trial settings dilutes observable anti-Wolbachia and antifilarial effects, making it difficult to estimate therapeutic efficacy and compare different doxycycline regimens, evaluated at different times after treatment. Methods. A meta-analytical modeling framework is developed to link all usable data collected from clinical trials measuring the Wolbachia status and viability of individual female adult worms collected at various times after treatment with 4, 5, or 6 weeks of daily 100 or 200 mg oral doxycycline. The framework is used to estimate efficacy parameters that are not directly measurable as trial outcomes. Results. The estimated efficacy of doxycycline (the maximum proportional reduction in the percentage of adult female O. volvulus positive for Wolbachia) is 91%–94% on average, irrespective of the treatment regimen. Efficacy is >95% in the majority of trial participants. The life span of Wolbachia-depleted worms is reduced by 70%–80%, from approximately 10 years to 2–3 years. Conclusions. The efficacy parameters are pertinent to the prospects of using doxycycline on a “test and treat” basis for onchocerciasis control and confirm doxycycline as a potent macrofilaricidal therapy. The modeling approach is more generally relevant to the design and evaluation of clinical trials for antifilarial drugs conducted in endemic settings.Keywords
This publication has 36 references indexed in Scilit:
- Doxycycline Improves Filarial Lymphedema Independent of Active Filarial Infection: A Randomized Controlled TrialClinical Infectious Diseases, 2012
- Long term impact of large scale community-directed delivery of doxycycline for the treatment of onchocerciasisParasites & Vectors, 2012
- Genetic Consequences of Mass Human Chemotherapy for Schistosoma mansoni: Population Structure Pre- and Post-Praziquantel Treatment in TanzaniaThe American Journal of Tropical Medicine and Hygiene, 2010
- Identifying sub-optimal responses to ivermectin in the treatment of River BlindnessProceedings of the National Academy of Sciences, 2009
- Newly acquired Onchocerca volvulus filariae after doxycycline treatmentParasitology Research, 2009
- Onchocerciasis Control: Vision for the Future from a Ghanian perspectiveParasites & Vectors, 2009
- Community-directed delivery of doxycycline for the treatment of onchocerciasis in areas of co-endemicity with loiasis in CameroonParasites & Vectors, 2009
- Wolbachia endobacteria depletion by doxycycline as antifilarial therapy has macrofilaricidal activity in onchocerciasis: a randomized placebo-controlled studyMedical Microbiology and Immunology, 2007
- River Blindness: A Success Story under Threat?PLOS Medicine, 2006
- Appropriate Models for the Management of Infectious DiseasesPLOS Medicine, 2005